TW200413008A - Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi - Google Patents

Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi Download PDF

Info

Publication number
TW200413008A
TW200413008A TW092118374A TW92118374A TW200413008A TW 200413008 A TW200413008 A TW 200413008A TW 092118374 A TW092118374 A TW 092118374A TW 92118374 A TW92118374 A TW 92118374A TW 200413008 A TW200413008 A TW 200413008A
Authority
TW
Taiwan
Prior art keywords
group
groups
general formula
complex
scope
Prior art date
Application number
TW092118374A
Other languages
English (en)
Chinese (zh)
Inventor
Bernd Misselwitz
Johannes Platzek
Yoko Kawata
Hanns-Joachim Weinmann
Takishi Yokawa
Niedballa Ulrich
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200413008A publication Critical patent/TW200413008A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW092118374A 2002-07-10 2003-07-04 Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi TW200413008A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10231799A DE10231799B4 (de) 2002-07-10 2002-07-10 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben

Publications (1)

Publication Number Publication Date
TW200413008A true TW200413008A (en) 2004-08-01

Family

ID=30009959

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092118374A TW200413008A (en) 2002-07-10 2003-07-04 Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi

Country Status (23)

Country Link
EP (1) EP1519756B1 (fr)
JP (1) JP2005532404A (fr)
CN (1) CN1668338A (fr)
AR (1) AR041187A1 (fr)
AT (1) ATE361103T1 (fr)
AU (2) AU2003281146A1 (fr)
BR (1) BR0312552A (fr)
CA (1) CA2491933A1 (fr)
DE (2) DE10231799B4 (fr)
DK (1) DK1519756T3 (fr)
ES (1) ES2285143T3 (fr)
IL (1) IL165889A0 (fr)
MX (1) MXPA04012950A (fr)
NO (1) NO20050679L (fr)
PE (1) PE20040656A1 (fr)
PL (1) PL374027A1 (fr)
PT (1) PT1519756E (fr)
RS (1) RS20050020A (fr)
RU (1) RU2328310C2 (fr)
TW (1) TW200413008A (fr)
UA (1) UA79294C2 (fr)
WO (2) WO2004006979A2 (fr)
ZA (1) ZA200501172B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
TW201034691A (en) * 2008-12-05 2010-10-01 Molecular Insight Pharm Inc Technetium-and rhenium-bis(heteroaryl) complexes and methods of use thereof
EP3101012A1 (fr) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
CN107445911B (zh) * 2017-06-19 2019-07-05 南京科技职业学院 一种二核含钆磁共振对比剂及其制备与应用
CN113164628A (zh) 2018-11-23 2021-07-23 拜耳股份有限公司 造影介质制剂及其制备方法
CN109867635A (zh) * 2019-02-14 2019-06-11 华东师范大学 一种t1型胶束磁共振成像造影剂及其制备方法
EP4059925A1 (fr) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Nouvel agent de contraste pour une utilisation dans l'imagerie par résonance magnétique
EP4335840A1 (fr) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Nouveaux agents de contraste pour l'imagerie diagnostique
EP4335462A1 (fr) 2022-09-09 2024-03-13 Bayer AG Nouveaux agents de contraste pour l'imagerie diagnostique par tomodensitometrie

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571498A (en) * 1994-06-02 1996-11-05 Hemagen/Pfc Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI).
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
WO1998016256A1 (fr) * 1996-10-16 1998-04-23 The Burnham Institute Imagerie par resonance magnetique utilisee detecter un thrombus
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
BR0013171A (pt) * 1999-07-29 2002-05-28 Epix Medical Inc Agentes multimericos para formação de imagem de objetivação através de ligação multi-local
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
DE10040380B4 (de) * 2000-08-11 2006-03-09 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques

Also Published As

Publication number Publication date
DE10231799A1 (de) 2004-02-12
EP1519756B1 (fr) 2007-05-02
RU2005103598A (ru) 2005-11-20
UA79294C2 (en) 2007-06-11
EP1519756A2 (fr) 2005-04-06
PL374027A1 (pl) 2005-09-19
ZA200501172B (en) 2006-04-26
PE20040656A1 (es) 2004-12-01
PT1519756E (pt) 2007-07-12
NO20050679L (no) 2005-04-08
AU2003281146A1 (en) 2004-02-02
CN1668338A (zh) 2005-09-14
JP2005532404A (ja) 2005-10-27
CA2491933A1 (fr) 2004-01-22
DE50307180D1 (de) 2007-06-14
IL165889A0 (en) 2006-01-15
AU2003281150A1 (en) 2004-02-02
WO2004006979A2 (fr) 2004-01-22
AR041187A1 (es) 2005-05-04
DE10231799B4 (de) 2006-10-05
MXPA04012950A (es) 2005-05-16
DK1519756T3 (da) 2007-08-13
WO2004006965A2 (fr) 2004-01-22
ES2285143T3 (es) 2007-11-16
ATE361103T1 (de) 2007-05-15
WO2004006965A3 (fr) 2004-07-15
RU2328310C2 (ru) 2008-07-10
BR0312552A (pt) 2005-04-26
RS20050020A (sr) 2007-08-03

Similar Documents

Publication Publication Date Title
Overoye-Chan et al. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus
CN103260652B (zh) 显示不依赖于浓度的响应性的cest系统
TW200306999A (en) Cascade polymer complexes, pharmaceutical compositions comprising the cascade polymer complexes and processes for the preparation of the pharmaceutical compositions
JP2003201258A (ja) 多座結合を介した多量体画像化剤の標的化
Wu et al. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer
JPH10502679A (ja) カスケードポリマー錯体、その製造方法及びこれらを含有する医薬
JP2002507977A (ja) ペルフルオロアルキル含有のオリゴマー化合物、その製造方法およびｎｍｒ診断法におけるその使用
TW200413008A (en) Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
AU2003290032B2 (en) Trimeric macrocyclically substituted benzene derivatives
KR100634246B1 (ko) 퍼플루오로알킬아미드, 이들의 제조, 및 진단 방법에서의이들의 용도
RU2289579C2 (ru) Перфторалкилсодержащие коплексы с полярными остатками, способ их получения, фармацевтическое средство
JP2009509915A (ja) ペルフルオロアルキル含有錯体、ならびにｎｍｒ、ｘ線および放射線診断、さらに放射線治療のための造影剤としてのその使用法
CN101687803B (zh) 具有全氟化的peg基团的金属螯合物、它们的制备方法及它们的用途
JP4310187B2 (ja) Ｘ線と核磁気共鳴との組み合わせ診断法で使用するためのイオン性及び非イオン性ｘ線写真造影剤
US7344704B2 (en) Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
US7208140B2 (en) Trimeric macrocyclic substituted benzene derivatives
JP2000514850A (ja) プソイドポリロタキサン
US6461587B1 (en) Perfluoroalkylamides, their production and their use in diagnosis
KR20050017095A (ko) 혈관내 혈전을 나타내기 위한 자기 공명 영상화에서의조영제로서 퍼플루오로알킬 함유 금속 착물의 용도